Tag:
Namenda
Latest Headlines
Latest Headlines
Forest profits reel as Lexapro faces first copycats
The company's profits plummeted 40% as its blockbuster antidepressant Lexapro fell off patent.
Forest earnings drop on higher costs
Forest Laboratories ( $FRX ) posted a drop in fiscal second-quarter earnings on higher costs, but sales rose 9%, thanks to strong early sales of two new products. But revenue still depends heavily on
Study: Forest Labs drug no help in mild Alzheimer's
Forest Laboratories' Namenda, an Alzheimer's med, didn't help stave off cognitive decline in patients with a mild form of the disease, researchers said, casting doubt on this off-label use of the
